11 hours ago
1
JHVEPhoto/iStock Editorial via Getty Images
Pharmaceutical giant Bristol-Myers Squibb (NYSE:BMY) shares inched up on Friday after six consecutive sessions of fall. The stock was up 2.1% at $44.20.
BMY’s shares lost nearly 11.6% in the preceding six sessions. On a year-to-date basis, they have lost 22.4%, compared to the broader market
English (US) ·